Combined Treatment With 131I-MIBG and Sunitinib Induces Remission in a Patient With Metastatic Paraganglioma Due to Hereditary Paraganglioma-Pheochromocytoma Syndrome From an SDHB Mutation.

Makis, William; McCann, Karey; McEwan, Alexander J B; Sawyer, Michael B

Makis, William; McCann, Karey; McEwan, Alexander J B; Sawyer, Michael B.

Affiliation

Makis W; From the Departments of *Diagnostic Imaging and Medical Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.

Clin Nucl Med ; 41(3): 204-6, 2016 Mar.

Article in En | MEDLINE | ID: mdl-26359568

Subject(s)

3-Iodobenzylguanidine/therapeutic use; Adrenal Gland Neoplasms/therapy; Indoles/therapeutic use; Pheochromocytoma/therapy; Pyrroles/therapeutic use; Succinate Dehydrogenase/genetics; 3-Iodobenzylguanidine/administration & dosage; Adrenal Gland Neoplasms/genetics; Adrenal Gland Neoplasms/pathology; Bone Neoplasms/secondary; Bone Neoplasms/therapy; Chemoradiotherapy; Female; Humans; Indoles/administration & dosage; Mutation; Pheochromocytoma/genetics; Pheochromocytoma/pathology; Pyrroles/administration & dosage; Remission Induction; Sunitinib

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pheochromocytoma / Pyrroles / Succinate Dehydrogenase / Adrenal Gland Neoplasms / 3-Iodobenzylguanidine / Indoles Limits: Female / Humans Language: En Journal: Clin Nucl Med Year: 2016 Document type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google